AMG 176
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AMG 176, covering 2025-07-09 to 2025-07-14. Get the full timeline:
Most recent: Clinical Trial Update: AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia [Phase 1]